Page last updated: 2024-10-27

furazolidone and Pneumonia, Pneumocystis

furazolidone has been researched along with Pneumonia, Pneumocystis in 1 studies

Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.

Pneumonia, Pneumocystis: A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walzer, PD1
Kim, CK1
Foy, J1
Zhang, JL1

Other Studies

1 other study available for furazolidone and Pneumonia, Pneumocystis

ArticleYear
Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:1

    Topics: Animals; Cell Nucleus; Drug Evaluation, Preclinical; Furazolidone; Male; Nitrofurantoin; Pneumocysti

1991